Showing results (231-240 of 1,206) with videos related to
Sort By:
Pageof 121
Antioxidants (Basel, Switzerland)|December 24, 2021
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOxJan Olof G Karlsson, Per Jynge, Louis J IgnarroAntioxidants (Basel, Switzerland)|March 29, 2023
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2Jan Olof G Karlsson, Per Jynge, Louis J IgnarroInternational Journal of Oncology|December 9, 2004
Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-IIIngirídur Skírnisdóttir, Tomas Seidal, Mats G Karlsson, et al.Leukemia Research|May 19, 1998
Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AMLM Fergedal, M Aström, U Tidefelt, et al.Biochemistry|May 23, 2000
Side-chain interactions in the plastocyanin-cytochrome f complexM Ejdebäck, A Bergkvist, B G Karlsson, et al.Oncology Reports|June 18, 2004
Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcomeM Graflund, B Sorbe, S Sigurdardóttir, et al.Journal of the American Society for Mass Spectrometry|May 4, 2004
Structural determination of neutral O-linked oligosaccharide alditols by negative ion LC-electrospray-MSnNiclas G Karlsson, Benjamin L Schulz, Nicolle H PackerActa Radiologica (Stockholm, Sweden : 1987)|February 27, 2008
Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomersC M Chai, J O G Karlsson, T AlménScientific Reports|November 3, 2019
Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance studyJan Eric Stehr, Ingemar Lundström, Jan Olof G KarlssonTranslational Oncology|July 3, 2017
Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)Jan Olof G Karlsson, Rolf Gg Andersson, Per JyngePageof 121